Evaluation of the impact of treatment delays and dose reductions on tumor response in human ovarian cancer xenograft models

被引：0
|
作者：
Hong, Jing [1 ]
Saucier, Jenifer M. [2 ]
Gaikwad, Anjah [2 ]
Brown, Jubilee [2 ]
Smith, Judith A. [1 ,2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston Med Sch, Houston, TX USA
来源：
REPRODUCTIVE SCIENCES | 2008年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
860
引用
收藏
页码：302A / 302A
页数：1
相关论文
共 50 条
  • [1] Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer
    Nagel, C. I.
    Backes, F. J.
    Hade, E. M.
    Cohn, D. E.
    Eisenhauer, E. L.
    O'Malley, D. M.
    Fowler, J. M.
    Copeland, L. J.
    Salani, R.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 221 - 224
  • [2] Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
    Maniati, Eleni
    Berlato, Chiara
    Gopinathan, Ganga
    Heath, Owen
    Kotantaki, Panoraia
    Lakhani, Anissa
    McDermott, Jacqueline
    Pegrum, Colin
    Delaine-Smith, Robin M.
    Pearce, Oliver M. T.
    Hirani, Priyanka
    Joy, Joash D.
    Szabova, Ludmila
    Perets, Ruth
    Sansom, Owen J.
    Drapkin, Ronny
    Bailey, Peter
    Balkwill, Frances R.
    CELL REPORTS, 2020, 30 (02): : 525 - +
  • [3] Effect of chemotherapy delays and dose reductions on progression-free and overall survival in the treatment of epithelial ovarian cancer
    Nagel, C.
    Backes, F.
    Donner, J.
    Hade, E.
    Copeland, L.
    Fowler, J.
    Cohn, D.
    O'Malley, D.
    Eisenhauer, E.
    Salani, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S123 - S123
  • [4] Effect of lanthanum chloride on tumor growth and apoptosis in human ovarian cancer cells and xenograft animal models
    Wang, Fen
    Zhu, Yuanfang
    Fang, Shanyu
    Li, Shuya
    Liu, Sisun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 1143 - 1148
  • [5] Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer
    Ricci, Francesca
    Guffanti, Federica
    Affatato, Roberta
    Brunelli, Laura
    Roberta, Pastorelli
    Fruscio, Robert
    Perego, Patrizia
    Bani, Maria Rosa
    Chiorino, Giovanna
    Rinaldi, Andrea
    Bertoni, Francesco
    Fratelli, Maddalena
    Damia, Giovanna
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (02): : 572 - +
  • [6] Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
    Shaw, TJ
    Senterman, MK
    Dawson, K
    Crane, CA
    Vanderhyden, BC
    MOLECULAR THERAPY, 2004, 10 (06) : 1032 - 1042
  • [7] Comparison of two kinds of orthotopic xenograft models for human ovarian cancer
    Zhu, Genhai
    Hong, Lan
    Wang, Shengtan
    Cai, Junhong
    Yang, Zhaoxin
    Yao, Maozhong
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (06) : 724 - 727
  • [8] Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
    Liu, Joyce F.
    Palakurthi, Sangeetha
    Zeng, Qing
    Zhou, Shan
    Ivanova, Elena
    Huang, Wei
    Zervantonakis, Ioannis K.
    Selfors, Laura M.
    Shen, Yiping
    Pritchard, Colin C.
    Zheng, Mei
    Adleff, Vilmos
    Papp, Eniko
    Piao, Huiying
    Novak, Marian
    Fotheringham, Susan
    Wulf, Gerburg M.
    English, Jessie
    Kirschmeier, Paul T.
    Velculescu, Victor E.
    Paweletz, Cloud
    Mills, Gordon B.
    Livingston, David M.
    Brugge, Joan S.
    Matulonis, Ursula A.
    Drapkin, Ronny
    CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1263 - 1273
  • [9] COMPARING THE IMPACT OF DOSE REDUCTIONS/ DELAYS ON OVARIAN CANCER OUTCOMES USING THREE WEEKLY OR DOSE DENSE CARBOPLATIN/ PACLITAXEL REGIMENS IN THE NATIONAL PROSPECTIVE OPAL COHORT
    Mileshkin, L.
    Sivakumaran, T.
    Grant, P.
    Na, L.
    Friedlander, M.
    Webb, P.
    Au-Yeung, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 770 - 770
  • [10] Zebrafish tumor-derived xenograft-models for improved diagnosis and treatment planning in ovarian cancer patients.
    Selvaraj, Karthik
    Vildevall, Malin
    Wirestam, Lina
    Ali, Zaheer
    Erkstam, Anna
    Abrahamsson, Annelie
    Kersley, Asa Rydmark
    Kjolhede, Preben
    Linder, Stig
    Dabrosin, Charlotta
    Fahlgren, Anna
    Jensen, Lasse
    CANCER RESEARCH, 2021, 81 (13)
12345